Funarunart Panrapee, Treesit Isaraporn
Department of Ophthalmology, Phramongkutklao Hospital, Phramongkutklao College of Medicine, Bangkok, 10400, Thailand.
Clin Ophthalmol. 2021 Mar 18;15:1193-1200. doi: 10.2147/OPTH.S300621. eCollection 2021.
The study aimed to evaluate the efficacy and predictive factors of success after selective laser trabeculoplasty (SLT) for treating various types of open-angle glaucoma in a Thai population.
The study employed a retrospective cohort design.
The study retrospectively recruited Thai subjects diagnosed with open-angle glaucoma receiving first time selective laser trabeculoplasty. Primary open-angle glaucoma (POAG), ocular hypertension (OHT) and other types of open-angle glaucoma were included. Reduced intraocular pressure (IOP) of 20% or decreased number of antiglaucoma drugs usage after SLT was defined as success. Various parameters were analyzed for association with SLT success.
Ninety-six eyes were recruited in the study. Mean pre- and postSLT IOP were 19.31±3.59 and 15.04±3.13 mmHg, respectively. IOP decreased significantly in all follow-up visits (p<0.001). Overall, 59.4% met the treatment endpoint. More than 10% postSLT IOP elevation at 1 hour was the only covariate positively associated with SLT success in both univariate (odds ratio (OR) = 1.042, p = 0.037) and multivariate analyses (OR = 1.040, p = 0.046). Underlying hypertension and preSLT IOP were negatively associated with SLT success in both univariate (OR = 0.970, p = 0.026, OR = 0.955, p < 0.001) and multivariate analysis (OR = 0.970, p = 0.026, OR = 0.991, p < 0.001).
IOP significantly decreased as well as the number of antiglaucoma drugs needed after SLT. More than 10% postSLT IOP elevation at 1 hour was a positive predictor whereas systemic hypertension and preSLT IOP were negative predictors of SLT success.
本研究旨在评估选择性激光小梁成形术(SLT)治疗泰国人群中各种类型开角型青光眼的疗效及成功的预测因素。
本研究采用回顾性队列设计。
本研究回顾性招募首次接受选择性激光小梁成形术的泰国开角型青光眼患者。纳入原发性开角型青光眼(POAG)、高眼压症(OHT)及其他类型开角型青光眼。SLT术后眼压降低20%或抗青光眼药物使用数量减少被定义为成功。分析各种参数与SLT成功的相关性。
本研究共纳入96只眼。SLT术前和术后平均眼压分别为19.31±3.59 mmHg和15.04±3.13 mmHg。在所有随访中眼压均显著降低(p<0.001)。总体而言,59.4%达到治疗终点。SLT术后1小时眼压升高超过10%是单因素分析(优势比(OR)=1.042,p = 0.037)和多因素分析(OR = 1.040,p = 0.046)中与SLT成功唯一呈正相关的协变量。基础高血压和SLT术前眼压在单因素分析(OR = 0.970,p = 0.026,OR = 0.955,p < 0.001)和多因素分析(OR = 0.970,p = 0.026,OR = 0.991,p < 0.001)中与SLT成功均呈负相关。
SLT术后眼压显著降低,所需抗青光眼药物数量也减少。SLT术后1小时眼压升高超过10%是成功的阳性预测因素,而全身性高血压和SLT术前眼压是SLT成功的阴性预测因素。